Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07809178 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm

Study acronym: ChTTSRUIA
StatusNot Yet Recruiting
PhaseNot specified
SponsorCheng sen
Started2026-09-01
View on ClinicalTrials.gov ↗
The goal of this observational study is to learn about the treatment strategies for tumor in sellar region with unruptured intracranial aneurysms in the Chinese population. The main question it aims to answer is: For patients with tumor in sellar region combined with unruptured intracranial aneurysms, which condition should be treated first?
Trial Details
NCT Number NCT07809178
Lead Sponsor Cheng sen
Collaborators: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, West China Hospital, Xijing Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Chongqing Medical University, Shengjing Hospital, Lanzhou University Second Hospital, The First Hospital of Jilin University, People's Hospital of Xinjiang Uygur Autonomous Region, Guangdong Provincial Hospital of Traditional Chinese Medicine, Huashan Hospital, Jinling Hospital, China
Conditions Unruptured Intracranial Aneurysms, Pituitary Neuroendocrine Tumor, Craniopharyngioma, Meningioma, Germinoma, Rathke Cleft Cysts, Chordoma, Optic Pathway Glioma +1 more
Enrollment 608 participants
Start Date 2026-09-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2031-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-09